iSpecimen Appoints Robert Lim as CEO and Director

Core Insights - iSpecimen Inc. has appointed Robert Lim as CEO and director, aiming to enhance its leadership and strategic direction in the biospecimen marketplace [1] Company Overview - iSpecimen operates an online marketplace that connects scientists with healthcare specimen providers, facilitating access to human biospecimens for medical research [6] - The company utilizes proprietary cloud-based technology to enable intuitive searches for specimens and patients across a network of healthcare organizations [6] Leadership Background - Robert Lim is the co-founder of De Novo Law Corporation, a law firm specializing in corporate and commercial law, bringing a forward-thinking approach to legal practice [2] - Prior to De Novo Law, Lim led Robert Bradley Lim Law Corporation, focusing on personalized legal counsel, and has experience in a prominent real estate and business law firm [3] - Lim's background includes marketing, having served as a marketing coordinator and founded a digital marketing agency, which contributes to his strategic approach in business [4][5] Strategic Vision - Lim emphasizes the importance of adaptability, growth, and profitability in business, expressing a commitment to help iSpecimen identify opportunities and enhance profit margins [5]